FDA approves Pfizer, Moderna updated KP.2 shots

FDA approves Pfizer, Moderna updated KP.2 shots

Pfizer COVID-19 vaccine. Courtesy: Pfizer The Food and Drug Administration on Thursday approved updated Covid vaccines from Pfizer and Moderna, putting the new shots on track to reach most Americans in the coming days amid a summer surge of the virus.  The jabs target a strain called KP.2, a descendant of the highly contagious omicron …

Read more

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

Insilico and NVIDIA unveil new LLM transformer for solving biological and chemical tasks

In a new paper, researchers from clinical stage artificial intelligence (AI)-driven drug discovery company Insilico Medicine (“Insilico”), in collaboration with NVIDIA, present a new large language model (LLM) transformer for solving biological and chemical tasks called nach0. The multi-domain and multi-task LLM was trained on a diverse set of tasks, natural language understanding, synthetic route …

Read more

Genetically Modified Cow Produces Human Insulin In Milk, Say Scientists

Genetically Modified Cow Produces Human Insulin In Milk, Say Scientists

Insulin for diabetics is primarily produced using genetically modified bacteria or yeast. Scientists have achieved a major breakthrough in the fight against diabetes. Researchers led by animal scientist Matt Wheeler from the University of Illinois at Urbana-Champaign have successfully produced a genetically modified cow whose milk contains human insulin. This research, published in the Biotechnology …

Read more

European scientists target high-risk childhood cancer with liquid biopsy

European scientists target high-risk childhood cancer with liquid biopsy

Neuroblastoma mainly affects toddlers and young children – in the EU region there are 1500 new cases per year. Neuroblastoma is a malignant tumor of the peripheral nervous system and around 50% of patients are high-risk cases. Recurrences occur frequently, and conventional therapies are no longer effective for these children. With liquid biopsies it is …

Read more

2024 expectations for Wegovy, Ozempic, Zepbound

2024 expectations for Wegovy, Ozempic, Zepbound

Demand for the drugs is unlikely to slow down in 2024, especially as treatments gradually become more accessible. Much of Wall Street believes the weight loss drug market will only expand, with some analysts projecting that it will be worth $100 billion by the end of the decade. Goldman Sachs analysts expect 15 million U.S. adults …

Read more

U.S. Covid shot rates are low and it will be a challenge to boost them

U.S. Covid shot rates are low and it will be a challenge to boost them

Covid shot uptake is slumping, and vaccine makers and health experts believe vaccination rates in 2024 and beyond will likely look similar to the uptake of the latest round of shots this year. The bigger uncertainty appears to be whether rates could increase down the line — and what would cause more people to roll …

Read more